重组干扰素-α 2b抗体患者中的白细胞源性干扰素-α - Suppr

Suppr

超能文献

Leucocyte-derived interferon-alpha in patients with antibodies to recombinant IFN-alpha 2b.

作者信息

von Wussow P, Hartmann F, Freund M, Poliwoda H, Deicher H

出版信息

Lancet. 1988 Apr 16;1(8590):882-3. doi: 10.1016/s0140-6736(88)91628-5.

DOI:10.1016/s0140-6736(88)91628-5

PMID:2895387

Abstract

摘要

相似文献

Leucocyte-derived interferon-alpha in patients with antibodies to recombinant IFN-alpha 2b.重组干扰素-α 2b抗体患者中的白细胞源性干扰素-α

Lancet. 1988 Apr 16;1(8590):882-3. doi: 10.1016/s0140-6736(88)91628-5.

Antibodies in patients with hairy-cell leukemia receiving alpha-2b interferon.接受α-2b干扰素治疗的毛细胞白血病患者的抗体。

N Engl J Med. 1986 Nov 27;315(22):1418. doi: 10.1056/nejm198611273152215.

Production of subtype-specific antipeptide antibodies to human interferon-alpha 1 and -alpha 4.针对人α-干扰素1和α-干扰素4亚型特异性抗肽抗体的制备。

J Interferon Res. 1988 Jun;8(3):325-32. doi: 10.1089/jir.1988.8.325.

Development of neutralizing interferon antibodies after treatment with recombinant interferon-alpha 2b in patients with malignant carcinoid tumors.

J Interferon Res. 1989 Sep;9 Suppl 1:S45-9.

Autoantibodies to crude human leucocyte interferon (IFN), native human IFN, recombinant human IFN-alpha 2b and human IFN-gamma in healthy blood donors.健康献血者体内针对粗制人白细胞干扰素（IFN）、天然人干扰素、重组人干扰素α2b和人干扰素γ的自身抗体。

Clin Exp Immunol. 1990 Oct;82(1):57-62. doi: 10.1111/j.1365-2249.1990.tb05403.x.

Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (Intron A).

Am J Med. 1986 Feb;80(2):223-8. doi: 10.1016/0002-9343(86)90013-6.

Humoral response to recombinant interferon-alpha 2b in patients receiving recombinant interferon-alpha 2b therapy.

J Interferon Res. 1989 Sep;9 Suppl 1:S25-31.

Low incidence of neutralizing antibody formation to interferon-alpha 2b in human recipients.人类受体中针对干扰素-α 2b产生中和抗体的发生率较低。

J Interferon Res. 1989 Sep;9 Suppl 1:S33-6.

Anti-interferon antibodies to interferon-alpha 2b: results of comparative assays and clinical perspective.

J Interferon Res. 1989 Sep;9 Suppl 1:S17-24.

Low incidence of anti-interferon-alpha antibodies in patients treated with interferon-alpha-2a for AIDS-associated Kaposi's sarcoma.接受α-2a干扰素治疗艾滋病相关卡波西肉瘤患者中抗α-干扰素抗体的低发生率

Int J STD AIDS. 1990 Jul;1(4):256-8. doi: 10.1177/095646249000100405.

引用本文的文献

Unified Total Synthesis of the Limonoid Alkaloids: Strategies for the De Novo Synthesis of Highly Substituted Pyridine Scaffolds.柠檬苦素类生物碱的统一全合成：高度取代吡啶骨架的从头合成策略。

Chem. 2022 Oct 13;8(10):2856-2887. doi: 10.1016/j.chempr.2022.09.012. Epub 2022 Oct 4.

Effect of dosing schedule on pharmacokinetics of alpha interferon and anti-alpha interferon neutralizing antibody in mice.给药方案对小鼠α干扰素药代动力学及抗α干扰素中和抗体的影响。

Antimicrob Agents Chemother. 2001 Jan;45(1):176-80. doi: 10.1128/AAC.45.1.176-180.2001.

Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C.慢性丙型肝炎治疗期间针对α干扰素（IFN-α）的中和抗体和结合抗体的生物学及临床意义

Clin Exp Immunol. 1994 Jul;97(1):4-9. doi: 10.1111/j.1365-2249.1994.tb06571.x.

Effects of type I-interferons on human thyroid epithelial cells derived from normal and tumour tissue.I型干扰素对源自正常和肿瘤组织的人甲状腺上皮细胞的影响。

Naunyn Schmiedebergs Arch Pharmacol. 1994 Sep;350(3):322-8. doi: 10.1007/BF00175039.

Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.用天然人干扰素α治疗一名对重组干扰素α-2b有抗体的慢性粒细胞白血病患者。

Blut. 1988 Nov;57(5):311-5. doi: 10.1007/BF00320360.

Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.干扰素α 2A（rbe）（罗扰素-A）治疗慢性乙型肝炎病毒（HBV）感染的随机对照试验：影响疗效的因素

Gut. 1989 Aug;30(8):1116-22. doi: 10.1136/gut.30.8.1116.

Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.淋巴细胞性干扰素α治疗欧洲裔慢性乙型肝炎病毒感染男性患者的随机对照试验。

BMJ. 1989 Sep 9;299(6700):652-6. doi: 10.1136/bmj.299.6700.652.

The use of interferon-alpha in virus infections.α干扰素在病毒感染中的应用。

Drugs. 1991 Nov;42(5):749-65. doi: 10.2165/00003495-199142050-00003.

Tumor necrosis factor alpha modifies resistance to interferon alpha in vivo: first clinical data.肿瘤坏死因子α在体内改变对α干扰素的抗性：首批临床数据。

Cancer Immunol Immunother. 1992;35(5):342-6. doi: 10.1007/BF01741148.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验